MIT Intensive Treatment Study

Stroke Clinical Trial

— MITTXS  

Official title:

Intensive MIT Paired With Video Feedback for Motor Speech Disorders and Aphasia

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT06213376
• Other study ID #: 2312-0370
• Status: Enrolling by invitation
• Phase: N/A
• Start date: December 28, 2023
• Est. completion date: June 2024

Study information

• Verified date: January 2024
• Source: Nevada State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 1
• Est. completion date: June 2024
• Est. primary completion date: February 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Fluent English speakers

• Sustained a left-hemisphere stroke

• Presents with language and motor speech impairments

Exclusion Criteria:

• • History of learning disability prior to accident (per patient report)

• Uncorrected auditory or visual impairments

• Not meeting the criteria of stroke

• Failure to provide evidence of stroke diagnosis (medical record history)

• History of psychiatric disorder

Related Conditions & MeSH terms

• Aphasia
• Stroke

Intervention

Behavioral:
• Melodic Intonation Therapy
Melodic Intonation Therapy uses intonation and melody to aid individuals with aphasia with producing words.
• Video Feedback Performance Review
Participant will view recording to judge correct and incorrect productions of trained words and to identify motor techniques increasing intelligibility

Locations

Country	Name	City	State
United States	Nevada State University	Henderson	Nevada

Sponsors (1)

Lead Sponsor	Collaborator
Nevada State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Intelligibility	Intelligibility as measured by percentage of consonants correct and by targets produced on trained and untrained stimuli. 20 trained and 20 untrained speech phrases that are relevant to the client (measured during reading and repetition tasks)	From enrollment to 4 weeks post treatment
Secondary	Apraxia Battery for Adults	A test to measure the presence and severity of apraxia in adults	Baseline and one week following the end of treatment
Secondary	Assessment of Intelligibility of Dysarthria Speech	A tool for quantifying single-word intelligibility, sentence intelligibility, and speaking rate of adult speakers with dysarthria	Baseline and one week following the end of treatment
Secondary	Longer Connected Speech Assessment	Change in Performance on Rainbow Passage- A public domain paragraph frequently used by speech-language pathologists to gather a speech sample of all phonemes for American English	Baseline and one and four weeks following the end of treatment
Secondary	Quality of Life with Dysarthria (QOLdys)	A reliable and valid tool to assess quality of life for patients with dysarthria.	Baseline and four weeks following treatments.